ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000477.1|Patellin_1 # 1 # 2016 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.559	BGC0000477.1|Patellin_1 	1	2016	+	Loose	500	32.7278	ANT(6)-Ib	31.75	3002629	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(6)	ATGAATAGAGATATTTTGCGAACTTTAAGTCTCAAAGGCGATCACAATATCCGGGTTGCTATTCTTGACGGTCCTGTCGATATAGCTCACCCCTGTTTCCAAGGATATGATCTGACCGTGCTTCCTACCCTGGCTCCTACGGCTGCCCGTAGTGACGGCTTTATGTCCGCCCACGGCACCCACGTTGCCAGTATTATTTTCGGTCAACCGGAAACTAGCGTTCCAGGTATCGCCCCCCAGTGTCGGGGTCTCATCGTCCCCATATTTTCCGACGATCGCAGGAGGATAACCCAGCTCGATCTAGCTCGGGGTATCGAGCGGGCGGTCAACGCCGGAGCCCACATTATCAACATCAGCGGCGGCGAACTCACCGACTTTGGCGAGGCGGATGGGTGGCTCGAAAATGCCGTTAGCCTGTGTCGGCAGAACAATGTTTTGCTCGTAGCTGCGGCAGGCAACAACGGCTGCGACTGCCTGCACGTTCCCGCCGCCCTACCGGCAGTATTGGCCGTAGGCGCAATGGACGAGCGGGGGCATCCCTTGGACTTTAGCAACTGGGGATCTACCTACGAGCAGCAGGGCATTCTCGCTCCCGGTGAAGATATTTTGGGGGCCAAGCCCGGTGGCGGCACGGAACGCCTCAGCGGCACCAGCTTTGCCACTCCGATTGTTTCCGGTGTCGCCGCCTTACTCCTGAGCGAGCAAGTTCGCCGGGGAGAAACCCCCGATCCCCAAAAAGTCCGCCAACTGTTGTTGCAGAGCGCCCTGCCCTGCGACGACGACGCGCCAGAACAGGCTCGGCGATGTCTGGCTGGCAGGCTGAACGTATCTGGAGCTTTCACTTTACTAAAAGGAGGAAATATGTCTGAAGAACTCGCAACGGCGAGTTTCCCTAGCGTAGAAGCATCCTGTGGCTGCAACGGCGGACTTGTCGCTGCGGAACCCACCACCAATTCCGGTTCGATGCCAGCTCTGTCGGTTTCCTCGTTCGCAGGGGCGAGTCCTGCCACTATGGAAGCCGCTGGCCCTCTCGAACCCCAACCTCTTCCATTCCCCGCCCAACCTCTTACACAAATGCCCGCCCAACCTCTTACACAAATGCCCGCCCCTACACAAACGCTCTCTATGACAACCAATCAAGTCACGCCCAGCCAAGCCCCCAGCGAACTTGCCAACAGTCAGTTCGCCTATGTCCTAGGAACCTTGGGCTACGACTTCGGCACCGAAGCTCGCCGCGACACCTTCAAGCAACTGATGCCGCCCTTTGACTTTGCAGGTAATATGGTTCCTGCCAACCCCTACGATGCCCGTCAGATGGTGGACTACTTGGGTAACAATATCTCAGAAGCGCGGTCTCTCATCTGGACCGTTAACATAGAACTGACCCCGGTCTATGCCATCGACCCAACCGGTCCTTTTGCCTCCGAAACCTACCACGCCCTTCAGGAACTGCTCTCCGGTCAAATCCAAGCTGAAGATAACGAAGAATACGTTGAGCGTGTCAGCATTCCCGGTGTTTTGACCAATCGCTCGGTCAAGCTCTTCTCCGGTCAAGTTGTCCCGGTGGTCGAACCCCAAAGCACTCGCGGTCTCTACGGTTGGAAGGTTAATGGCTTGGTAAATGCTGCCCTGGAGGCAGTTCGCGCTGAAGGAGGGGATGCAGGAGAAGCACGCATTCGCCAAACCTTGGATGGCTTTCTCAACCGCATCTACTACGACCTGCGCAACCTGGGAACCACTTCCCAAGACCGCGCCCTTAACTTTGCGGTTACCAACGCCTTCCAAGCCGCCCAAACCTTTAGCCAATCCGTGGCGGCGGGCATGGAACTCGACAGCGTTACTGTGGAGAAAAGTCCCTTCTGTCGCCTAGATAGCGATTGCTGGGATATAAAGTTAAAATTCTTCGACCCAGAAAACAACCGTCGTGCCAAGAAGATTTACCGATTTACCATTGATGTGAGCGATCTGGTTCCAGTGACTATGGGCGAAGTTCGTTCTTGGTCTTCTTCTTACTAA	MNRDILRTLSLKGDHNIRVAILDGPVDIAHPCFQGYDLTVLPTLAPTAARSDGFMSAHGTHVASIIFGQPETSVPGIAPQCRGLIVPIFSDDRRRITQLDLARGIERAVNAGAHIINISGGELTDFGEADGWLENAVSLCRQNNVLLVAAAGNNGCDCLHVPAALPAVLAVGAMDERGHPLDFSNWGSTYEQQGILAPGEDILGAKPGGGTERLSGTSFATPIVSGVAALLLSEQVRRGETPDPQKVRQLLLQSALPCDDDAPEQARRCLAGRLNVSGAFTLLKGGNMSEELATASFPSVEASCGCNGGLVAAEPTTNSGSMPALSVSSFAGASPATMEAAGPLEPQPLPFPAQPLTQMPAQPLTQMPAPTQTLSMTTNQVTPSQAPSELANSQFAYVLGTLGYDFGTEARRDTFKQLMPPFDFAGNMVPANPYDARQMVDYLGNNISEARSLIWTVNIELTPVYAIDPTGPFASETYHALQELLSGQIQAEDNEEYVERVSIPGVLTNRSVKLFSGQVVPVVEPQSTRGLYGWKVNGLVNAALEAVRAEGGDAGEARIRQTLDGFLNRIYYDLRNLGTTSQDRALNFAVTNAFQAAQTFSQSVAAGMELDSVTVEKSPFCRLDSDCWDIKLKFFDPENNRRAKKIYRFTIDVSDLVPVTMGEVRSWSSSY	MKMRTEKQIYDTILNFAKADDRIRVVTLEGSRTNINIIPDDFQDYDITFFVTDMQSFINSDEWLNVFGERLIMQKPEDMELFPKEEKGYSYLMLFWDGVKIDLTLLPLEVLDEYFTWDKLVKLLLDKDNRVTNIPVPTDEDYYIEHPTARSFDDCCNEFWNTVTYVVKGLCRKEILFAIDHLNNIVRMELLRMISWKVGIEQGYSFSLGKNYKFLERYISPELWKKILATYNMGSYTEMWKSLELCMGIFRMVSKEVAQCLNYLYPDYDKNISNYVIRQKEKYQR	235.44	gnl|BL_ORD_ID|1018|hsp_num:0	1113			51	231	streptomycin
BGC0000477.1|Patellin_2 # 2251 # 2487 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.498	BGC0000477.1|Patellin_2 	2251	2487	+	Loose	400	22.7126	catA4	32.35	3004657	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGCGACTTCCGCTACTGTCTGCCCCTGTAAAACGCCCTCATTTCATCCAGCCTGCTCAATGTGTAGATATTGAGAATGGCCGTCTTAAAGATTTGCTACATATTCGCCTAGAGCTTCTTGATGGTGCTAACTATAATGACCCGCCAGCCTTTGCCAACCGCAGTTTCAACCAAGTGATGCACTCGAGTGCCAGCAATGGCTGGGGCGGGTTTGCCAGTATGGGACGCTTATTCTGA	MRLPLLSAPVKRPHFIQPAQCVDIENGRLKDLLHIRLELLDGANYNDPPAFANRSFNQVMHSSASNGWGGFASMGRLF	MDTKRVGILVVDLSQWGRKEHFEAFQSFAQCTFSQTVQLDITSLLKTVKQNGYKFYPTFIYIISLLVNKHAEFRMAMKDGELVIWDSVNPGYNIFHEQTETFSSLWSYYHKDINRFLKTYSEDIAQYGDDLAYFPKEFIENMFFVSANPWVSFTSFNLNMANINNFFAPVFTIGKYYTQGDKVLMPLAIQVHHAVCDGFHVGRLLNEIQQYCDEGCK	35.94	gnl|BL_ORD_ID|2198|hsp_num:0	3357			366	468	chloramphenicol
BGC0000477.1|Patellin_3 # 2660 # 2854 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.523	BGC0000477.1|Patellin_3 	2660	2854	+	Loose	700	25.409	ADC-202	31.11	3006371	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamases pending classification for carbapenemase activity	ATGGTCACTAACAACCCTACCGCACAATCTAAAACGCCTCCTGCTGAGAAGAGAAAGTCTTACGTCATGACTTCTATGACGGGTATGCAAGACTACTCTTATTGGTGCGCCTACGTCCGCGAGCGCTACGGGGAAGAGGCGAAAAAATACGAACGCGATCCCCAGCCTTTCCGACGAGGGGGGGTTTGGGCTTAA	MVTNNPTAQSKTPPAEKRKSYVMTSMTGMQDYSYWCAYVRERYGEEAKKYERDPQPFRRGGVWA	MRFKKISCLLLPPLFIFSTSIYAGNTQKEQEVKKLVDQNFKPLLDKYDVPGMAVGVIQNNKKYEIYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKAKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKTKNAIGEYRQYSNPSIGLFGKIVALSMNKPFDQVLEKTIFPPLHLKNSYVNVPKTQMQNYAYGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLTFINANLNPQKYPKDIQHAINETHQGFYQVGTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGSYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	16.71	gnl|BL_ORD_ID|3200|hsp_num:0	4267			609	723	
BGC0000477.1|Patellin_4 # 2952 # 5297 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.532	BGC0000477.1|Patellin_4 	2952	5297	+	Loose	1650	29.6462	Brucella suis mprF	39.39	3003772	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	ATGCAACCAACCGCCCTCCAAATTAAGCCCCACTTCCACGTTGAGATAATTGAGCCGAAGCAAGTGTATCTCCTGGGCGAACAGGGCAACCACGCTCTCACCGGGCAGCTCTACTGCCAAATTCTGCCTTTCTTAAACGGCGAATACACCCGAGAACAAATTGTGGAAAAGCTCGATGGGCAGGTCCCGGAGGAATATATCGACTTCGTACTCAGTCGTCTGGTGGAGAAGGGCTATCTAACTGAGGTGGCTCCAGAACTATCCCTGGAAGTGGCAGCATTTTGGAGCGAATTGGGAATTGCCCCTTCTGTAGTGGCAGAAGGGCTAAAGCAGCCAGTGACAGTGACAACGGCGGGCAAGGGCATTAGGGAAGGGATAGTGGCTAACCTGGCAGCAGCGCTGGAGGAAGCTGGCATTCAGGTGTCAGACCCAAGGGACCCAAAGGCCCCAAAGGCAGGGGATTCTACTGCCCAGCTTCAGGTGGTGCTGACCGATGACTATTTACAGCCGGAACTTGCAGCGATCAACAAGGAAGCCTTAGAGCGCCAACAACCCTGGTTGCTGGTTAAGCCTGTGGGCAGTATCCTCTGGTTGGGACCGTTGTTCGTTCCTGGGGAAACCGGATGTTGGCACTGTCTTGCTCAACGATTGCAAGGCAACCGGGAAGTTGAAGCATCGGTATTGCAACAAAAGCGAGCGCTGCAGGAGCGCAACGGTCAAAATAAAAATGGTGCAGTGAGTTGCTTGCCCACAGCACGGGCAACCCTACCTTCTACTCTACAAACAGGTTTACAGTGGGCTGCCACTGAGATTGCTAAGTGGATGGTCAAGCGGCACCTCAATGCCATAGCACCGGGAACGGCTCGTTTTCCCACTCTAGCTGGCAAGATATTTACATTCAACCAGACGACTCTGGAGTTGAAAGCTCATCCTCTGAGCCGACGACCGCAATGTCCCACCTGTGGCGATCGGGAAACTCTCCAACGGCGCGGGTTTGAACCACTGAAGCTAGAGTCGCGCCCCAAACACTTCACCTCCGATGGCGGTCATCGCGCCATGACCCCAGAACAAACGGTGCAGAAGTACCAACACCTCATCGGGCCCATAACGGGGGTAGTGACGGAACTGGTGCGAATTTCTGACCCTGCCAATCCCTTGGTGCATACCTACCGGGCTGGGCATAGCTTTGGCAGTGCTACGTCTCTGCGGGGGCTGCGCAATGTCCTACGCCACAAGAGTTCTGGTAAAGGCAAGACCGATAGCCAATCTCGGGCCAGCGGACTTTGCGAGGCGATCGAGCGCTATTCGGGCATTTTTCAGGGAGACGAACCCCGCAAGCGGGCAACTTTGGCTGAGTTGGGAGATTTGGCGATTCATCCAGAACAGTGTTTGCACTTTAGCGACAGGCAGTATGACAACCGGGAAAGCTCGAACGAGCGAGCAACAGTGACTCACGACTGGATTCCCCAACGGTTCGATGCAAGTAAGGCTCACGACTGGACTCCCGTGTGGTCCCTAACGGAGCAAACCCATAAGTATCTGCCTACAGCCCTGTGCTATTACCGATACCCCTTCCCCCCAGAACACCGTTTCTGCCGTAGTGACTCCAACGGAAACGCGGCGGGAAATACCCTGGAAGAGGCGATTTTGCAAGGATTTATGGAACTGGTGGAACGGGATAGCGTGTGCCTGTGGTGGTACAATCGCGTTAGCCGTCCGGCTGTGGATTTGAGTAGCTTTGACGAGCCTTATTTTTTGCAGTTGCAGCAGTTCTATCAAACTCAAAATCGCGATCTGTGGGTACTGGATTTAACAGCAGATTTGGGCATTCCGGCTTTTGTAGGGGTATCGAATCGGAAAGCCGGCAGCTCGGAAAGAATAATTCTCGGCTTTGGAGCGCACCTGGACCCGACAGTTGCCATCCTTCGCGCTCTTACGGAGGTCAACCAAATAGGCTTGGAATTGGATAAAGTTTCTGATGAGAGCCTCAAGAACGATGCCACGGATTGGTTAGTGAATGCTACATTGGCAGCTAGTCCCTATCTCGTTGCCGATGCTAGCCAACCCCTCAAGACTGCGAAGGATTATCCCCGGCGTTGGAGTGACGATATTTACACCGATGTGATGACTTGTGTAGAAATAGCCAAGCAAGCAGGTCTAGAGACTTTGGTACTGGATCAGACCAGACCCGACATAGGTTTAAATGTGGTTAAAGTCATTGTGCCAGGAATGCGTTTTTGGTCGCGATTTGGCTCCGGTCGGCTCTATGACGTGCCAGTGAAGTTGGGATGGCGAGAGCAACCACTTGCTGAGGCACAAATGAACCCTACACCGATGCCATTTTAA	MQPTALQIKPHFHVEIIEPKQVYLLGEQGNHALTGQLYCQILPFLNGEYTREQIVEKLDGQVPEEYIDFVLSRLVEKGYLTEVAPELSLEVAAFWSELGIAPSVVAEGLKQPVTVTTAGKGIREGIVANLAAALEEAGIQVSDPRDPKAPKAGDSTAQLQVVLTDDYLQPELAAINKEALERQQPWLLVKPVGSILWLGPLFVPGETGCWHCLAQRLQGNREVEASVLQQKRALQERNGQNKNGAVSCLPTARATLPSTLQTGLQWAATEIAKWMVKRHLNAIAPGTARFPTLAGKIFTFNQTTLELKAHPLSRRPQCPTCGDRETLQRRGFEPLKLESRPKHFTSDGGHRAMTPEQTVQKYQHLIGPITGVVTELVRISDPANPLVHTYRAGHSFGSATSLRGLRNVLRHKSSGKGKTDSQSRASGLCEAIERYSGIFQGDEPRKRATLAELGDLAIHPEQCLHFSDRQYDNRESSNERATVTHDWIPQRFDASKAHDWTPVWSLTEQTHKYLPTALCYYRYPFPPEHRFCRSDSNGNAAGNTLEEAILQGFMELVERDSVCLWWYNRVSRPAVDLSSFDEPYFLQLQQFYQTQNRDLWVLDLTADLGIPAFVGVSNRKAGSSERIILGFGAHLDPTVAILRALTEVNQIGLELDKVSDESLKNDATDWLVNATLAASPYLVADASQPLKTAKDYPRRWSDDIYTDVMTCVEIAKQAGLETLVLDQTRPDIGLNVVKVIVPGMRFWSRFGSGRLYDVPVKLGWREQPLAEAQMNPTPMPF	MLWWDDISMSLIDDEIPSSQPQVSGRHFGWLKQYQHFLFPIAGIAIALLAIYVLENLLRHTSRTETLAALHNISWTTLALAVFFTALSYAAVALYDVVAVDTIAPNQIPRRIAAVAGAAGYAISNALGFSLLTGGALRYRIYAAEGISLADIGKIVGTSWFAIWFALIIMVGAALLIDPQDVPFLSAIDIRIDIVAGILILGGIGWLIYWLSHGERNVSIGSFSLRLPNSKGALTQIFAGVVDVGAAAATLYVLLPEGAVPSFAVFALVYVIAIVLGIASHAPGGLGAFEATIIAGLGLGGKPDAIAGLLAYRLIYTVLPLVVATAGILIWEVMRRRHMLDKQARFAKRLVEPLVPGLSASIIFLGGIILLISGATPDMRYRVKLLSDIVPEFLVEMSHLAASLVGVALLIVARGLSKRLERAWVAAMVLLLCGAVFSIAKGLDWEEASILCLFALSLWGFRDSFYRRPIAGPFELSWNWIATVGTTVLVSTWLGFFVYRHIEYSSDLWWDFAWNGNAPRFLRATVLVFAVVAAVGLHSIINRHGQRRRKVDHSIPDAVPALVARCPHTDAALAMLGDKQFLLAPDDSAFIMYAQSGGSLIALGEPIGDAEAGKELAWSFHSLADRLALRTVFYGVGPQSLPLFLDMGLIALKLGEVARVDLTDFSLEGPRRQPFRYADRKVDKDGLTFEIIPAADVPPLIPRLRAISDAWLDHKSGSEKGFSLGYFNDEYLKRFDIAVLKKDGEIVAFANIWRGADKYEITVDLMRYMPNVHKLLMDALFAKLLTFSKQEGYKWFNLGAAPLSGLSGSRLASRWNRFGSFIYRRGADLYHFDGLKAFKEKFDPVWTPHYMVCPGGLETPRALLDATTLINGSPLEFIRK	88.75	gnl|BL_ORD_ID|2057|hsp_num:0	2281			90	189	defensin
BGC0000477.1|Patellin_5 # 5431 # 5631 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.547	BGC0000477.1|Patellin_5 	5431	5631	+	Loose	2090	24.2534	cmeB	40.0	3000784	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; cephalosporin; fusidane antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAACAAAAAAAACATTCTGCCCCAACTAGGCCAACCCGTCATCCGCTTGACTGCTGGTCAACTCTCCAGCCAGTTGGCTGAACTCTCTGAGGAAGCTCTCGGTGGCGTGGATGCCTCGACCTTACCTGTTCCTACCCTCTGCTCTTACGACGGCGTGGATGCCTCGACCGTTCCTACCCTCTGCTCTTACGACGACTAA	MNKKNILPQLGQPVIRLTAGQLSSQLAELSEEALGGVDASTLPVPTLCSYDGVDASTVPTLCSYDD	MFSKFFIERPVFASVVAIIISLAGVIGLTNLPIEQYPSLTPPTVKVSATYTGADAQTIASTVASPIEDAINGADNMIYMDSTSSSSGTMSLTVYFDIGTDPDQATIDVNNRISAATAKMPDAVKKLGVTVRKTSSATLAAISMYSSDGSMSAVDVYNYIALNVLDELKRVPGVGDANAIGNRNYSLRIWLKPDLLNKFKITATDVISAVNDQNAQYATGKIGEEPVTQKSPYVYSITMQGRLQNPSEFENIILRTNDDGSFLRLKDIADVEIGSQQYSSQGRLNGNDAVPIIINLQSGANALHTAELVQAKMQELSKNFPKGLTYKIPYDTTKFVIESIKEVIKTFIEALILVIIVMYMFLKNFRATLIPMIAVPVSLLGTFAGLYVLGFSINLLTLFALILAIGIVVDDAIIVVENIDRILHENEQISVKDAAIQAMQEVSSPVISIVLVLCAVFIPVSFISGFVGEIQRQFALTLAISVTISGFVALTLTPSLCALFLRRNEGEPFKFVRKFNDFFDWSTSVFSAGVAYILKRTIRFVLIFCIMLGTIFYLNKAVPNSLVPEEDQGLMIGIINLPSASALHRTISEVDHISQEVLKTNGIKDAMAMIGFDLFTSSLKENAAAMFIGLQDWKDRNVSADKIAMELNKKFAFDRNASSIFIGLPPIPGLSITGGFEMYVQNKSGKSYDQIQKDVNKLVAAANQRKELSRVRTTLDTTFPQYKLIIDRDKLKHYNLNMQDVFNTMNATIGTYYVNDFSMLGKNFQVNIRAKGDFRNTQDALKNIFVRSNDGKMIPLDSFLTLQRSSGPDDVKRFNLFPAAQVQGQPAPGYTSGQAIEAIAQVAKETLGDDYSIAWSGSAYQEVSSKGTASYAFALGMIFVFLILAAQYERWLIPLAVVTAVPFAVFGSFLLVYLRGFSNDIYFQTGLLLLIGLSAKNAILIVEFAMEERFKKGKGVFEAAVAAAKLRFRPIIMTSLAFTFGVLPMIFATGAGSASRHSLGTGLIGGMIAASTLAIFFVPLFFYLLENFNEWLDKKRGKIHE	6.35	gnl|BL_ORD_ID|689|hsp_num:0	748			2466	2541	erythromycin; cefotaxime; fusidic acid
BGC0000477.1|Patellin_6 # 5968 # 6882 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.389	BGC0000477.1|Patellin_6 	5968	6882	+	Loose	400	25.7942	vatE	36.36	3002844	protein homolog model	n/a	n/a	streptogramin antibiotic; streptogramin A antibiotic	antibiotic inactivation	streptogramin vat acetyltransferase	ATGACTACTACTTGGCCAGATAGCTATGCAAAAGAGCGGCGCATTCAACGCCTACGCCATCATTTTGAGTCTTTTGATGTGGAACGGGCTTTTCCTTTGCCTCTTTTTGAGCAAGCCGTTTTGAGTCTAGACAGTTGTCCACTCTTGGAACCCTCTTTTAAAGTACAAGAAGGCATATTATTCGCAGGTAGAGTTACTACTTCTACCGGTACGGAAGACTGGCAGCACTTAATTAGCACGGCTCTGAATTTTTTTGATGCAGTTGAAAGTAGAGTAGAAGTGACCATCGACCGTGGTTTATTAGAGAAATTTTTAACGCTTCATCAAAACTCTGACAAAATCGAAGCAAGTTTGATGGGAATTGATTTACGTCCGAATGTTAAAGAGTCTAGTCTTAAAGTTCACCTTCGGCTTGACCCGCAACAAGATGCTGACGAACTGGTGATGACAGCTATCGATCTTGATGGCGGTGATTATTCACCGGAGCTGACGCAAGTTCTTCTGAAAGATACATTTTTGATTGGCTTTGATTTTTTCTTAGACGGTGGCAGTGCTGTGGAAATGTATACTATTTGTCCTGGTAAAAAACCATTAGCCATGTTAGGTAAAAAGGGGGCTTATCTAAAACCTTATGTATTAAGTAATTTTTCTCATAAAGTAACTTCCTTGTTGCAAGAGGTAGCTGCTCTCACAGTAGGCTTTTCCAAAGAAAATCCTAGACCAGTTTTGTATTTTGAATTTGAAACTTTACGAGAGGTAAAGTATAATCTGTTATTCAATAGCTTGGGAGATAAGATTTATGATTTTTGTCTTCATAATCAAATTGAAAATTTTGTCAGTATTGGGGTTACAGAACCAGATTTAGAGAAAAGGAGGTTGGAAAATTTCCGTTTCTATTATCGCAAGGCGGTATAG	MTTTWPDSYAKERRIQRLRHHFESFDVERAFPLPLFEQAVLSLDSCPLLEPSFKVQEGILFAGRVTTSTGTEDWQHLISTALNFFDAVESRVEVTIDRGLLEKFLTLHQNSDKIEASLMGIDLRPNVKESSLKVHLRLDPQQDADELVMTAIDLDGGDYSPELTQVLLKDTFLIGFDFFLDGGSAVEMYTICPGKKPLAMLGKKGAYLKPYVLSNFSHKVTSLLQEVAALTVGFSKENPRPVLYFEFETLREVKYNLLFNSLGDKIYDFCLHNQIENFVSIGVTEPDLEKRRLENFRFYYRKAV	MTIPDANAIYPNSAIKEVVFIKNVIKSPNIEIGDYTYYDDPVNPTDFEKHVTHHYEFLGDKLIIGKFCSIASGIEFIMNGANHVMKGISTYPFNILGGDWQQYTPELTDLPLKGDTVVGNDVWFGQNVTVLPGVKIGDGAIIGANSVVTKDVAPYTIVGGNPIQLIGPRFEPEVIQALENLAWWNKDIEWITANVPKLMQTTPTLELINSLMEK	142.06	gnl|BL_ORD_ID|1398|hsp_num:0	1519			288	405	virginiamycin M1; madumycin II; griseoviridin; dalfopristin
